Jin Medical International Ltd. current report, Q4 FY2023

Filing Summary

Business Context and Reporting Period

Jin Medical International Ltd., a foreign private issuer headquartered in Changzhou, Jiangsu Province, China, filed Form 6-K for December 2023. The filing was signed on December 26, 2023.

Material Corporate Change

On December 21, 2023, Jing Chen resigned as chairperson of the audit committee and as an independent director of the Company. The resignation was effective immediately and was not related to any disagreement with the Company’s accounting policies.

Financial Metrics and Outlook

This filing does not provide financial statements, revenue, profit, cash flow, margins, debt, liquidity metrics, guidance, or management’s financial outlook.

Governance Considerations and Risks

The resignation creates a change in the composition and leadership of the audit committee and board. The filing does not state whether a replacement has been appointed or describe the effect on the Company’s compliance with applicable corporate governance requirements.

Key Facts to Verify

  • Whether the Company has appointed a replacement independent director or audit committee chair.
  • Whether the board and audit committee continue to satisfy applicable listing and corporate governance requirements.
  • Any subsequent disclosures regarding the reasons for the resignation or changes to board committees.
  • Financial performance and liquidity information, which are not included in this Form 6-K.